Market Research Report
Dermatoscopes Market Analysis Report By Technology (LED, Xenon, Halogen, UV), By Product (Contact, Hybrid, Noncontact), By Modality (Handheld, Headband), By End Use, And Segment Forecasts, 2018 - 2025
|Published by||Grand View Research, Inc.||Product code||744635|
|Published||Content info||98 Pages
Delivery time: 2-3 business days
|Dermatoscopes Market Analysis Report By Technology (LED, Xenon, Halogen, UV), By Product (Contact, Hybrid, Noncontact), By Modality (Handheld, Headband), By End Use, And Segment Forecasts, 2018 - 2025|
|Published: October 16, 2018||Content info: 98 Pages||
The global dermatoscopes market size is expected to reach USD 1.7 billion by 2025, according to a new report by Grand View Research, Inc., registering a CAGR of 13.6% during the forecast period. Dermatoscopy plays a vital role in screening for skin cancer, which has resulted in early detection and identification of pigmented lesions. Benign pigmented moles possess a certain risk of developing melanoma.
Skin cancer is a chronic disease affecting a large population of the world. Rising incidence of melanoma and nonmelanoma skin cancers is providing an upthrust to the market. Certain moles, such as giant congenital pigmented hairy moles, are at high risk of developing melanoma. This has boosted the need for effective diagnosis with dermatoscopes.
In April 2016, The Skin Cancer Foundation initiated a month-long education and fundraising campaign during the Skin Cancer Awareness month. Early detection has been proved to be very useful in its effective treatment. Hence, rising number of awareness campaigns is estimated to fuel the demand for dermatoscopes, which is anticipated to propel the market. Earlier, the usage of these technologically advanced devices was limited to detection of noninvasive melanoma. However, with technological advancements, their application has widened to advanced diagnosis of various skin disorders.
Some of the key market participants are: 3Gen; Optilia; Firefly Global; HEINE Optotechnik GmbH & Co. KG; FotoFinder Systems, Inc.; Caliber Imaging & Diagnostics, Inc.; ILLUCO Corporation Ltd.; Bio-Therapeutic, Inc.; and Welch Allyn